None listed
Conditions
Brief summary
Borderline personality disorder represents an important challenge for clinicians and family members. It is known that relatives are frequently involved in patients’ crisis and find themselves in need of handling them. It is also well estabilished that family members of BPD patients can show psychiatric conditions that may play an important role on BPD’s progress. For these reasons an interpersonal psychotherapeutic approach appears particularly suitable in form of Interpersonal Councelling because it acts on the dysfunctional relational patterns. Interpersonal counselling shares a double purpose: a) acting on patient’s relatives psychiatric symptoms, global functioning, quality of life and perceived stress; b) acting through relatives, modifying the interpersonal relationship with the patient itself in order to offer him a more adaptative model he may adopt as a model for other interpersonal relationships. As the current literature on a IPT-based counselling is scarce, the results of this study could provide useful new evidence and inspire the launch of an outpatient project to be shared with other clinics, both hospital and territorial. The hypothesis of our study is that an intervention aimed at the relatives of BPD patients can lead to clinical benefit for both the patient as well as the family.
Interventions
Interventions:
1) 6 interpersonal counselling meetings lasting 60 minutes delivered once a fortnight. The meetings are aimed at a relative cohabitant of BPD patient. The sessions will be held by a psychiatrist. Goals and techniques used in these meetings will follow the standardized Revised Interpersonal Psychotherapy adapted for treating Borderline Personality Disorder (IPT-BPD-R) model for the entire duration of the intervention. The meetings take place after outpatient access and registrati
Interventions: 1) 6 interpersonal counselling meetings lasting 60 minutes delivered once a fortnight. The meetings are aimed at a relative cohabitant of BPD patient. The sessions will be held by a psychiatrist. Goals and techniques used in these meetings will follow the standardized Revised Interpersonal Psychotherapy adapted for treating Borderline Personality Disorder (IPT-BPD-R) model for the entire duration of the intervention. The meetings take place after outpatient access and registration in the secretariat in the form of individual psychotherapy. 2) 90-minute clinical interviews with administration of psychometric scales at t0 and t1, i.e. before the start and after the conclusion of the intervention. The sessions will be held face-to-face by a psychiatrist, in the presence of a psychologist. 3) 90-minute clinical interviews for BPD patients, with administration of psychometric scales at t0 and t1, i.e. before the start and after the conclusion of the intervention. The sessions will be held face-to-face by a psychiatrist, in the presence of a psychologist.
Sponsors
University of Turin (UniTo)
Study design
Allocation
Non-randomised trial
Primary purpose
Educational / counselling / training
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
Consecutive (20-75 years), family members of patients diagnosed with BPD according to DSM-5 criteria will be enrolled. The diagnosis is made by evaluation by experienced clinicians and by administration of SCID-5 (Structured Clinical Interview for DSM-5 personality disorders). The inclusion criteria for patients require a diagnosis made by evaluation by experienced clinicians and by administration of SCID-5 (Structured Clinical Interview for DSM-5 personality disorders).
Exclusion criteria
Exclusion criteria for relatives: a) Presence of neuropsychiatric comorbidities, assessed according to DSM-5 criteria and including: neurodevelopmental disorders; neurocognitive disorders; schizophrenia and schizophrenic spectrum disorders; bipolar disorder; b) Concomitant major depressive episode and/or active substance use; c) A personality disorder that emerged at the SCID-5-PD interview. Exclusion criteria for patients: a) Presence of neuropsychiatric comorbidities, assessed according to DSM-5 criteria and including: neurodevelopmental disorders; neurocognitive disorders; schizophrenia and schizophrenic spectrum disorders; bipolar disorder; b) Concomitant major depressive episode and/or active substance use; c) Symptomatological severity judged by the clinician to be incompatible with adaptation to the setting.
Outcome results
None listed